Zafgen, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
E Zafgen Soars 78% On Positive Phase 3 Obesity Results
Article By: Terry Chrisomalis Thursday, January 21, 2016 4:53 AM EDT
Yesterday, shares of Zafgen, Inc. closed up 78% after the company had announced positive phase 3 results in patients with obesity.
In this article: ZFGN
Read
Why The Dow Jones Industrial Average Fell Today - December 3, 2015
Article By: Money Morning Thursday, December 3, 2015 9:00 PM EDT
The Dow Jones Industrial Average today plunged 252 points after ECB President Mario Draghi surprised the markets by cutting interest rates and boosting stimulus below Wall Street's expectations for the euro bloc's monetary intervention.
In this article: BIG, BKS, CVX, KMI, PFE, VRX, XOM, GILD, GOOG, YHOO, BABA, FB, GOOGL, ZFGN
Read
E Shares Of Zafgen Fell 60% After Reporting Another Patient Death For Obesity Trial
Article By: Terry Chrisomalis Wednesday, December 2, 2015 10:30 PM EDT
The obesity trial is being turn to treat patients with a rare disease known as Prader-Will Syndrome. This syndrome causes the ability for patients to be hungry all the time, which causes the foundation for long-term obesity.
In this article: ZFGN Also: ARNA, OREX, VVUS
Read
E Zafgen Announces FDA Partial Clinical Hold On Obesity Trials
Article By: Terry Chrisomalis Friday, October 16, 2015 12:30 PM EDT
Shares of Zafgen are down 32% today after the FDA announced a partial clinical hold on the company's obesity trials.
In this article: ZFGN
Read
Zafgen - Chart Of The Day
Article By: Jim Van Meerten Wednesday, March 18, 2015 4:31 PM EDT
The Chart of the Day belongs to Zafgen (ZFGN). Since the Trend Spotter signaled a buy on 1/22 the stock gained 26.74%.
In this article: ZFGN
Read
PlasmaTech Announces Reverse Stock Split, Launches New Corporate Website; CEL-SCI Announces Closing Of Public Offering
Article By: BioMedReports Sunday, October 26, 2014 6:36 PM EDT
BioMed Reports takes a look at some of the headlines for companies that made news in the healthcare sector this week...
In this article: CVM, ACCP, SIMH, RDNT, TNDM, ACET, CUTR, MYGN, QLTI, ZFGN, HIIQ, HQY, ALDR, MCIG, OXFD, PINC
Read
CRMD Announces FDA IND Filing For Neutrolin; ZFGN Completes Enrollment Of Phase 2a Trial Of Beloranib
Article By: BioMedReports Friday, September 26, 2014 6:58 AM EDT
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease.
In this article: CRMD, ZFGN
Read
1 to 7 of 7 Posts